Both recombinant and natural human IgG2 antibodies have several different disulfide bond isoforms, which possess different global structures, thermal stabilities, and biological activities. A detailed mapping of the structural difference among IgG2 disulfide isoforms, however, has not been established. In this work, we employed hydrogen/deuterium exchange mass spectrometry to study the conformation of three major IgG2 disulfide isoforms known as IgG2-B, IgG2-A1, and IgG2-A2 in two recombinant human IgG2 monoclonal antibodies. By comparing the protection factors between amino acid residues in isoforms B and A1 (the classical form), we successfully identified several local regions in which the IgG2-B isoform showed more solvent protection tha...
Antibody-drug conjugates (ADCs) are a newer class of targeted biologics that combine the specificity...
We report the stabilization of the human IgG1 Fc fragment by engineered intradomain disulfide bonds....
Human IgG2 antibody displays distinct therapeutically-useful properties compared with the IgG1, IgG3...
Both recombinant and natural human IgG2 antibodies have several different disulfide bond isoforms, w...
ABSTRACT: In this communication we present the detailed disulfide structure of IgG2 molecules. The c...
Human IgG2 antibody displays distinct therapeutically-useful properties compared with the IgG1, IgG3...
The immunoglobulin (Ig) constant CH2 domain is critical for antibody effector functions. Isolated CH...
The immunoglobulin (Ig) constant CH2 domain is critical for antibody effector functions. Isolated CH...
The immunoglobulin (Ig) constant CH2 domain is critical for antibody effector functions. Isolated CH...
Protein therapeutics, monoclonal antibodies (mAbs) in particular, are large, structurally complex mo...
Abstract Generally, intermolecular disulfide bond contribute to the conformational protein stability...
Antibodies protect from infection, underpin successful vaccines and elicit therapeutic responses in ...
Background:Immunoglobulin domains owe a crucial fraction of their conformational stability to an inv...
Antibodies protect from infection, underpin successful vaccines and elicit therapeutic responses in ...
Immunoglobulin G (IgG) monoclonal antibodies (mAbs) are a major class of medicines, with high specif...
Antibody-drug conjugates (ADCs) are a newer class of targeted biologics that combine the specificity...
We report the stabilization of the human IgG1 Fc fragment by engineered intradomain disulfide bonds....
Human IgG2 antibody displays distinct therapeutically-useful properties compared with the IgG1, IgG3...
Both recombinant and natural human IgG2 antibodies have several different disulfide bond isoforms, w...
ABSTRACT: In this communication we present the detailed disulfide structure of IgG2 molecules. The c...
Human IgG2 antibody displays distinct therapeutically-useful properties compared with the IgG1, IgG3...
The immunoglobulin (Ig) constant CH2 domain is critical for antibody effector functions. Isolated CH...
The immunoglobulin (Ig) constant CH2 domain is critical for antibody effector functions. Isolated CH...
The immunoglobulin (Ig) constant CH2 domain is critical for antibody effector functions. Isolated CH...
Protein therapeutics, monoclonal antibodies (mAbs) in particular, are large, structurally complex mo...
Abstract Generally, intermolecular disulfide bond contribute to the conformational protein stability...
Antibodies protect from infection, underpin successful vaccines and elicit therapeutic responses in ...
Background:Immunoglobulin domains owe a crucial fraction of their conformational stability to an inv...
Antibodies protect from infection, underpin successful vaccines and elicit therapeutic responses in ...
Immunoglobulin G (IgG) monoclonal antibodies (mAbs) are a major class of medicines, with high specif...
Antibody-drug conjugates (ADCs) are a newer class of targeted biologics that combine the specificity...
We report the stabilization of the human IgG1 Fc fragment by engineered intradomain disulfide bonds....
Human IgG2 antibody displays distinct therapeutically-useful properties compared with the IgG1, IgG3...